8,444-share sale reported for Argan Inc. (NYSE: AGX) in Form 144 filing

Rhea-AI Filing Summary

Argan Inc. submitted a Form 144 notice reporting proposed or recent secondary sales of common stock. The filing shows a reported sale by William Leimkuhler of 8,444 shares for $5,053,538 on 04/13/2026. The filing also lists securities tied to earlier transactions: 5,000 shares from a 07/20/2020 stock option exercise and two 400-share open-market purchase entries dated 10/07/2013 and 10/08/2013.

Key Figures

Reported sale: 8,444 shares Aggregate proceeds: $5,053,538 Option exercise shares: 5,000 shares +1 more

4 metrics

Reported sale 8,444 shares Sale by William Leimkuhler on 04/13/2026

Aggregate proceeds $5,053,538 Proceeds reported for the 8,444-share sale on 04/13/2026

Option exercise shares 5,000 shares Stock option exercise dated 07/20/2020 listed in securities-to-be-sold

Open-market purchases (examples) 400 shares; 400 shares Open-market purchase entries dated 10/07/2013 and 10/08/2013

Key Terms

Form 144, Stock Option Exercise, Open Market Purchase

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 07/20/2020 | Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Open Market Purchase market

"Common | 10/07/2013 | Open Market Purchase"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	5000	3304250.00	13945962	04/28/2026	NYSE
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	400	264340.00	13945962	04/28/2026	NYSE
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	400	264340.00	13945962	04/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2020	Stock Option Exercise	Issuer			5000	07/20/2020	Cash/Check
Common	10/07/2013	Open Market Purchase	Issuer			400	10/07/2013	Cash/Check
Common	10/08/2013	Open Market Purchase	Issuer			400	10/08/2013	Cash/Check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William Leimkuhler 4075 Wilson Boulevard, Suite 440 Arlington VA 22203	Argan Inc	04/13/2026	8444	5053538.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Argan Inc. (AGX) disclose in this Form 144?

The Form 144 discloses a reported sale of 8,444 shares by William Leimkuhler for $5,053,538 on 04/13/2026, plus entries reflecting a 5,000-share option exercise on 07/20/2020 and two 400-share open-market purchases in 2013.

Who executed the 8,444-share sale reported in the filing?

The sale is reported in the filing under the name William Leimkuhler with an address listed in Arlington, VA. The record shows the sale of 8,444 shares and aggregate proceeds of $5,053,538 on 04/13/2026 as entered in the excerpt.

Are there other securities or transactions listed in the Form 144 excerpt?

Yes. The excerpt lists a 5,000-share entry tied to a 07/20/2020 stock option exercise and two 400-share open-market purchase entries dated 10/07/2013 and 10/08/2013. Those entries are shown under the securities-to-be-sold section.

Does the filing state who receives the proceeds from the reported sale?

The provided excerpt shows aggregate proceeds of $5,053,538 for the 8,444-share sale but does not specify proceeds recipients or allocation beyond the seller name and the aggregate amount shown in the record.